Search Results for "administer chemotherapy"

ONS member Donna Bydlon, BSN, RN, OCN^®, network director of infusion services at St. Luke's University Hospital and Health Network in Bethlehem, PA, and member of the Greater Lehigh Valley ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss nursing considerations for monoclonal antibodies to treat cancer and COVID-19 and how her institution responded to the pandemic. This episode is part of an ongoing series about outpatient oncology drug infusion. Other series' episodes are linked in the episode notes.

ONS member Elizabeth Bettencourt, RN, MSN, OCN^®, oral chemotherapy nurse navigator at Palo Alto Medical Foundation in Sunnyvale, CA, joins Kristine B. LeFebvre MSN, RN, AOCN^®, oncology clinical specialist at ONS, to discuss the challenges of oral anticancer drugs, how to monitor and educate patients, the best resources available to oncology nurses, and more.

Kristine B. LeFebvre, MSN, RN, NPD-BC, AOCN^®, ONS oncology clinical specialist, joins Chris Pirschel, ONS staff writer/producer, to discuss chemotherapy administration in non-oncology settings, how oncology nurses can support their non-oncology colleagues, and ways institutions are addressing the demand for oncology RNs in a variety of settings.

ONS member Jennifer Turcotte, RN, BSN, OCN^®, clinic manager at New England Cancer Specialists in Scarborough, ME, and member of the Southern Maine ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss safety considerations and what nurses need to know when administering FOLFOX chemotherapy regimens.

ONS member Barbara Zoltick, CRNP, nurse practitioner at the University of Pennsylvania in Philadelphia and member of the Bucks-Montgomery Counties ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss nursing considerations for the treatment of patients with advanced or metastatic urothelial cancer. Seagen Inc. provided support for this podcast episode through an educational grant. 

ONS member Joaquin Buitrago, MS, RN, OCN^®, nurse educator at the University of Texas MD Anderson Cancer Center in Houston and member of the Houston ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss multiple myeloma and its implications for nursing care, including the pathophysiology of the disease, treatment considerations, and clinical practice recommendations to promote the best patient outcomes. The development of this episode was supported by a sponsorship from Janssen Oncology. 

Hazardous drugs are not just used in oncology, and their health risks for providers go far beyond reproductive toxicities. ONS member MiKaela Olsen, DNP, APRN-CNS, AOCNS^®, FAAN, clinical program director in oncology at the Johns Hopkins Hospital and Johns Hopkins Health System in Baltimore, MD, talks with Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, about protecting yourself and your colleagues with the latest updates in hazardous drug safety, including a change for the process of doffing personal protective equipment (PPE).

ONS member Clara Beaver, MSN, RN, AOCNS^®, ACNS-BC, clinical nurse specialist at Karmanos Cancer Institute in Detroit, MI, member of the ONS Metro Detroit Chapter, and secretary/treasurer for the Oncology Nursing Certification Corporation (ONCC) Board of Directors, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss intravesicular chemotherapy, how it differs from other chemotherapy treatments, and safe handling recommendations that oncology nurses should be aware of.

Lisa Kennedy-Sheldon, PhD, ANP-BC, AOCNP^®, FAAN, ONS clinical and scientific affairs liaison, joins Chelsea Backler, MSN, APRN, AGCNS-BC, AOCNS^®, ONS oncology clinical specialist and former home care nurse, to discuss how the COVID-19 coronavirus pandemic affects antineoplastics administration and safety considerations for in-home cancer care. More information is available in ONS’s recent position statement, linked in the episode notes.

This episode is supported by an educational grant from Genentech, a member of the Roche Group. ONS is solely responsible for the criteria, objectives, content, quality, and scientific integrity of its programs and publications.

ONS member Seth Eisenberg, RN, ADN, OCN^®, BMTCN^®, professional practice coordinator of infusion services at Seattle Cancer Care Alliance in Washington and member of the Puget Sound ONS Chapter, joins Chris Pirschel, ONS staff writer/producer, to discuss the important aspects of safe handling in oncology nursing, what the upcoming USP chapter launch will mean for practice, and how healthcare professionals can advocate for safety in their institutions.